Note: This is just a small subset of all of the python projects I've created. The one showcased are much more entertaining to look at have some graphical component to them. LINKS: Hangman: <a href=" ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company that integrates technological ...

Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...

Small businesses have long supplied a disproportionate share of major innovations in the United States. We review a centerpiece policy on this topic: the US Small Business Innovation Research (SBIR) ...

REC-3565 is a potential best-in-class MALT1 inhibitor for multiple hematology indications, designed to reduce the risk of hyperbilirubinemia, a common side effect of other MALT1 inhibitorsREC-4539, a ...

All told, Recursion is “deprioritizing” three clinical-stage programs, pausing another and winding down a single preclinical program in an undisclosed target, the company revealed in its first ...

Recursion will host a (L)earnings Call on May 5, 2025 at 8:00 am ET / 6:00 am MT / 1:00 pm BST from Recursion’s X (formerly Twitter), LinkedIn, and YouTube accounts giving analysts, investors ...

Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program, in a pruning ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing it with AI. Read my RXRX stock thesis.

Recursion trumpeted the results as if they were successful, but this program isn't going anywhere fast. The company still hasn't announced plans to launch a phase 3 study for REC-994, the ...

Cathie Wood in a latest program on CNBC talked about Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) and explained why she’s bullish on the stock because of AI catalysts: ...

The fund will provide up to $250,000 in capital, 12 months of lab space and access to Altitude Lab’s accelerator program for biotech startups that have been reviewed for Small Business ...